Abstract
Migraine is a complex debilitating neurovascular disease affecting approximately 15% of the Western populations. Familial clustering, twin studies and segregation analyses suggest that migraine has a significant genetic component, but the number of genes involved remains unclear. The progress in migraine genetics has recently jumped ahead with the identification of genes responsible for Familiar Hemiplegic Migraine (FHM), a rare subtype of migraine with aura showing autosomal dominant mode of inheritance. Nevertheless, the knowledge about common types of migraine has been particularly rewarding and recently, seven loci with significant linkage to migraine with or without aura have been identified on 1q31, 4q24, 6p12.2-21.1, 11q24, 14q21.2-q22.3, 15q11-q13 and Xq24-28, suggesting the presence of migraine susceptibility genes in these regions. Identification of genes predisposing to the more common and genetically complex forms of migraine has been complicated by clinical and genetic heterogeneity of the disease. The major challenge in the coming years facing biomedical research of migraine is the identification of disease-susceptibility genes and the understanding of how migraine risk can be influenced by the interaction of these variants with each other and with specific environmental factors in order to provide individuals with clinically-useful diagnostic, prognostic and therapeutic information. This paper briefly summarizes the previous knowledge and highlights some recent developments in the complex genetic nature of migraine.
Keywords: Familial hemiplegic migraine, migraine with aura, migraine without aura
Current Genomics
Title: The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Volume: 7 Issue: 1
Author(s): Fernando Gianfrancesco and Teresa Esposito
Affiliation:
Keywords: Familial hemiplegic migraine, migraine with aura, migraine without aura
Abstract: Migraine is a complex debilitating neurovascular disease affecting approximately 15% of the Western populations. Familial clustering, twin studies and segregation analyses suggest that migraine has a significant genetic component, but the number of genes involved remains unclear. The progress in migraine genetics has recently jumped ahead with the identification of genes responsible for Familiar Hemiplegic Migraine (FHM), a rare subtype of migraine with aura showing autosomal dominant mode of inheritance. Nevertheless, the knowledge about common types of migraine has been particularly rewarding and recently, seven loci with significant linkage to migraine with or without aura have been identified on 1q31, 4q24, 6p12.2-21.1, 11q24, 14q21.2-q22.3, 15q11-q13 and Xq24-28, suggesting the presence of migraine susceptibility genes in these regions. Identification of genes predisposing to the more common and genetically complex forms of migraine has been complicated by clinical and genetic heterogeneity of the disease. The major challenge in the coming years facing biomedical research of migraine is the identification of disease-susceptibility genes and the understanding of how migraine risk can be influenced by the interaction of these variants with each other and with specific environmental factors in order to provide individuals with clinically-useful diagnostic, prognostic and therapeutic information. This paper briefly summarizes the previous knowledge and highlights some recent developments in the complex genetic nature of migraine.
Export Options
About this article
Cite this article as:
Gianfrancesco Fernando and Esposito Teresa, The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes, Current Genomics 2006; 7 (1) . https://dx.doi.org/10.2174/1389202910607010001
DOI https://dx.doi.org/10.2174/1389202910607010001 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Challenges for ACE-Inhibitors in Vascular Diseases
Drug Design Reviews - Online (Discontinued) Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
Current Medicinal Chemistry Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Current Pharmaceutical Design Diffuse Correlation Spectroscopy (DCS): A Diagnostic Tool for Assessing Tissue Blood Flow in Vascular-Related Diseases and Therapies
Current Medical Imaging Prodrug Strategies in Ocular Drug Delivery
Medicinal Chemistry Post-locoregional Therapy MRI Evaluation of Malignant Liver Lesions
Current Cancer Therapy Reviews Ezetimibe and Reactive Oxygen Species
Current Vascular Pharmacology Metabolic Effects of Renal Denervation
Current Clinical Pharmacology Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
Current Medicinal Chemistry Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
Current Pharmaceutical Design Nitric Oxide-Dependent Neovascularization Role in the Lower Extremity Disease
Current Pharmaceutical Design Vascular Effects of Insulin and Their Relation to Endothelial Dysfunction, Insulin Resistance and Hypertension
Current Hypertension Reviews Determination of Phytochemicals by GC-MS in Two Fractions (17 and 21) of Methanol Extract of Loranthus Micranthus and their Antioxidant and Anti-Inflammatory Activity
The Natural Products Journal Recent Developments in the Stereocontrolled Synthesis of Highly Substituted Cyclopentane Core Structures: From Drug Discovery Research to Natural Product Synthesis
Current Organic Chemistry The Airway Neurogenic Inflammation: Clinical and Pharmacological Implications
Inflammation & Allergy - Drug Targets (Discontinued) Pathophysiology of Coronary Collaterals
Current Cardiology Reviews Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach
Inflammation & Allergy - Drug Targets (Discontinued)